Overview


According to FutureWise analysis the market for Pharmaceutical Unit Dose Packaging in 2023 is US$ 34.2 billion, and is expected to reach US$ 104.76 billion by 2031 at a CAGR of 15.00%.

Unit dose packaging, also known as regulatory packaging or compliance packaging, is a nonreusable, barcoded container used to distribute single-dose pharmaceuticals. It retains a certain amount of medication in single-use containers to ensure that the patient receives the correct dose when he or she requires it. In clinics and hospitals, both solid and liquid medications are frequently used. Single-dose packaging was developed as a result of continuous packaging industry innovation to help patients receive safe and effective medication. This form of packaging was judged the safest because there was no possibility of the prescription being refilled, and it reduced the number of misdoes. This product now has a broader range of uses as a result of these benefits, as well as improvements in lifestyle and increased domination of contemporary style culture. The market will expand as healthcare spending and the pharmaceutical sector in emerging economies both increase. Advances in biotechnology will drive the growth of the primary packaging segment, resulting in the introduction of new injectable parenteral therapies as well as increased demand for high visibility unit dosage packaging for diseases like diabetes, both of which will provide lucrative growth opportunities for the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Unit Dose Packaging Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pharmaceutical Unit Dose Packaging Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • SGD SA
  • Stevanato Group S.p.a.
  • Klockner Pentaplast Group
  • UDG Healthcare plc.
  • Amcor plc.
  • Berry Global, Inc.
  • Comar LLC.
  • Constantia Flexibles Group GmbH
  • Nipro Corporation
  • Catalent, Inc.
  • Becton, Dickinson and Company
  • Adelphi Healthcare Packaging
  • Winpak Ltd.
  • Faw Foundry
  • Pacific Vial Manufacturing Inc.
  • Sonoco Products Company
  • WestRock Company
  • AptarGroup, Inc.
  • Shanghai Tongpeng Electric Material Co., Ltd
  • Tonbay Industry Co., Ltd.
  • Borosil Limited
  • Piramal Glass Private Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Blisters Pharmaceutical Unit Dose Packaging
  • Ampoules Pharmaceutical Unit Dose Packaging
  • Vials Pharmaceutical Unit Dose Packaging
  • Prefilled Syringes Cartridges

By Material

  • Plastic Pharmaceutical Unit Dose Packaging
    • Polyethylene(PE)
      • High Density Polyethylene (HDPE)
      • Low Density Polyethylene (LDPE)
    • Polypropylene Pharmaceutical Unit Dose Packaging
    • Poly vinyl chloride(PVC) Pharmaceutical Unit Dose Packaging
    • Polyethylene Terephthalate (PET) Pharmaceutical Unit Dose Packaging
  • Aluminum Pharmaceutical Unit Dose Packaging
  • Glass Pharmaceutical Unit Dose Packaging
  • Paper and Paperboard Pharmaceutical Unit Dose Packaging

By End User

  • Ophthalmic
  • Injectable
  • Biologics
  • Wound Care
  • Respiratory Therapy
  • Orals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Pharmaceutical Unit Dose Packaging Market By Product, By Material, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pharmaceutical Unit Dose Packaging Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Unit Dose Packaging Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pharmaceutical Unit Dose Packaging Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pharmaceutical Unit Dose Packaging Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blisters Pharmaceutical Unit Dose Packaging
        2. Ampoules Pharmaceutical Unit Dose Packaging
        3. Vials Pharmaceutical Unit Dose Packaging
        4. Prefilled Syringes Cartridges

  • 8.   Pharmaceutical Unit Dose Packaging Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plastic Pharmaceutical Unit Dose Packaging
         1.1. Polyethylene(PE)
          1.1.1. High Density Polyethylene (HDPE)
          1.1.2. Low Density Polyethylene (LDPE)
         1.2. Polypropylene Pharmaceutical Unit Dose Packaging
         1.3. Poly vinyl chloride(PVC) Pharmaceutical Unit Dose Packaging
         1.4. Polyethylene Terephthalate (PET) Pharmaceutical Unit Dose Packaging
        2. Aluminum Pharmaceutical Unit Dose Packaging
        3. Glass Pharmaceutical Unit Dose Packaging
        4. Paper and Paperboard Pharmaceutical Unit Dose Packaging

  • 9.   Pharmaceutical Unit Dose Packaging Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Ophthalmic
        2. Injectable
        3. Biologics
        4. Wound Care
        5. Respiratory Therapy
        6. Orals

  • 10.   North America Pharmaceutical Unit Dose Packaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Pharmaceutical Unit Dose Packaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Pharmaceutical Unit Dose Packaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Pharmaceutical Unit Dose Packaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Gerresheimer AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. West Pharmaceutical Services, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Schott AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. SGD SA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Stevanato Group S.p.a.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Klockner Pentaplast Group
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. UDG Healthcare plc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Amcor plc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Berry Global, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Comar LLC.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Constantia Flexibles Group GmbH
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Nipro Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Catalent, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Becton, Dickinson and Company
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Adelphi Healthcare Packaging
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Winpak Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Faw Foundry
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Pacific Vial Manufacturing Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Sonoco Products Company
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. WestRock Company
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. AptarGroup, Inc.
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Shanghai Tongpeng Electric Material Co., Ltd
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. Tonbay Industry Co., Ltd.
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24. Borosil Limited
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25. Piramal Glass Private Limited
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients